Kaleon S.p.A. (EPA:ALKLN)
3.900
0.00 (0.00%)
Last updated: Sep 9, 2026, 1:03 PM CET
Kaleon Revenue
In the year 2025, Kaleon had annual revenue of 23.77M EUR with 9.31% growth. Kaleon had revenue of 12.37M in the half year ending December 31, 2025.
Revenue
23.77M
Revenue Growth
+9.31%
P/S Ratio
2.32
Revenue / Employee
261.18K
Employees
91
Market Cap
55.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.77M | 2.02M | 9.31% |
| Dec 31, 2024 | 21.74M | 123.93K | 0.57% |
| Dec 31, 2023 | 21.62M | 8.00M | 58.69% |
| Dec 31, 2019 | 13.62M | 1.29M | 10.45% |
| Dec 31, 2018 | 12.34M | 1.74M | 16.42% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Solutions 30 SE | 892.40M |
| Aurea | 222.72M |
| SA Catana Group | 175.97M |
| Bilendi | 91.55M |
| Coheris | 16.28M |
| Rebirth | 6.89M |
| MaaT Pharma | 4.52M |
| AB Science | 1.17M |